These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 32568197)
1. Towards a Redefinition of Cognitive Frailty. Mantovani E; Zucchella C; Schena F; Romanelli MG; Venturelli M; Tamburin S J Alzheimers Dis; 2020; 76(3):831-843. PubMed ID: 32568197 [TBL] [Abstract][Full Text] [Related]
2. Emerging biomarkers and screening for cognitive frailty. Ruan Q; D'Onofrio G; Sancarlo D; Greco A; Lozupone M; Seripa D; Panza F; Yu Z Aging Clin Exp Res; 2017 Dec; 29(6):1075-1086. PubMed ID: 28260159 [TBL] [Abstract][Full Text] [Related]
3. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia]. Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ; Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080 [TBL] [Abstract][Full Text] [Related]
4. Potential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty. Ruan Q; D'Onofrio G; Sancarlo D; Greco A; Yu Z Mol Med Rep; 2016 Oct; 14(4):3184-98. PubMed ID: 27511317 [TBL] [Abstract][Full Text] [Related]
5. Different Cognitive Frailty Models and Health- and Cognitive-related Outcomes in Older Age: From Epidemiology to Prevention. Panza F; Lozupone M; Solfrizzi V; Sardone R; Dibello V; Di Lena L; D'Urso F; Stallone R; Petruzzi M; Giannelli G; Quaranta N; Bellomo A; Greco A; Daniele A; Seripa D; Logroscino G J Alzheimers Dis; 2018; 62(3):993-1012. PubMed ID: 29562543 [TBL] [Abstract][Full Text] [Related]
9. Epidemiological and clinical significance of cognitive frailty: A mini review. Sugimoto T; Sakurai T; Ono R; Kimura A; Saji N; Niida S; Toba K; Chen LK; Arai H Ageing Res Rev; 2018 Jul; 44():1-7. PubMed ID: 29544875 [TBL] [Abstract][Full Text] [Related]
10. Motoric cognitive risk syndrome, physio-cognitive decline syndrome, cognitive frailty and reversibility with dual-task exercise. Merchant RA; Chan YH; Hui RJY; Tsoi CT; Kwek SC; Tan WM; Lim JY; Sandrasageran S; Wong BLL; Chen MZ; Ng SE; Morley JE Exp Gerontol; 2021 Jul; 150():111362. PubMed ID: 33887381 [TBL] [Abstract][Full Text] [Related]
11. Targeting Cognitive Frailty: Clinical and Neurobiological Roadmap for a Single Complex Phenotype. Panza F; Seripa D; Solfrizzi V; Tortelli R; Greco A; Pilotto A; Logroscino G J Alzheimers Dis; 2015; 47(4):793-813. PubMed ID: 26401761 [TBL] [Abstract][Full Text] [Related]
12. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R; Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606 [TBL] [Abstract][Full Text] [Related]
13. Cross-Sectional Association Between Cognitive Frailty and White Matter Hyperintensity Among Memory Clinic Patients. Sugimoto T; Ono R; Kimura A; Saji N; Niida S; Toba K; Sakurai T J Alzheimers Dis; 2019; 72(2):605-612. PubMed ID: 31594230 [TBL] [Abstract][Full Text] [Related]
14. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE). Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768 [TBL] [Abstract][Full Text] [Related]
15. Increasing use of cognitive measures in the operational definition of frailty-A systematic review. Vella Azzopardi R; Beyer I; Vermeiren S; Petrovic M; Van Den Noortgate N; Bautmans I; Gorus E; Ageing Res Rev; 2018 May; 43():10-16. PubMed ID: 29408342 [TBL] [Abstract][Full Text] [Related]
16. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease. Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028 [TBL] [Abstract][Full Text] [Related]
17. Cognitive reserve and long-term change in cognition in aging and preclinical Alzheimer's disease. Soldan A; Pettigrew C; Cai Q; Wang J; Wang MC; Moghekar A; Miller MI; Albert M; Neurobiol Aging; 2017 Dec; 60():164-172. PubMed ID: 28968586 [TBL] [Abstract][Full Text] [Related]
18. Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults. Bilgel M; An Y; Helphrey J; Elkins W; Gomez G; Wong DF; Davatzikos C; Ferrucci L; Resnick SM Brain; 2018 Aug; 141(8):2475-2485. PubMed ID: 29901697 [TBL] [Abstract][Full Text] [Related]
19. The Case for Stage-Specific Frailty Interventions Spanning Community Aging to Cognitive Impairment. Chong MS; Tay L; Ismail NH; Tan CH; Yew S; Yeo A; Ye R; Leung B; Ding YY J Am Med Dir Assoc; 2015 Nov; 16(11):1003.e13-9. PubMed ID: 26543008 [TBL] [Abstract][Full Text] [Related]